$174.02+7.58% · 3M
Moving avg
1W-0.47%
1M-3.64%
3M+7.58%
6M-11.90%
YTD+11.53%
1Y+23.86%
3Y-51.73%
5Y-75.29%
52-week range
$122.0060% of range$208.31
Company health
Value3/6
Growth5/6
Profitability5/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 18% upside to a $205 target
- Analyst consensus is "Buy"
- High return on equity (1070%)
- Revenue compounding 16% a year
- Net cash on the balance sheet
Risks
- More volatile than the market (beta 1.7)
Key statistics
Valuation
Market cap
$12.46B
Enterprise value
$11.07B
P/E ratio (TTM)
28.09x
P/S ratio (TTM)
2.93x
EV/EBITDA
12.16x
Per share & returns
EPS (TTM)
$6.02
Dividend yield
0.00%
Beta (1Y)
1.67
30-day change
-3.64%
Trading
Volume (24h)
582.35K
Previous close
$172.96
Shares outstanding
71.62M
About Align Technology, Inc.
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Symbol
ALGN
Align Technology, Inc. is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NASDAQ (United States) and trade under the ticker ALGN.
Frequently asked questions
What is Align Technology, Inc.'s market cap?
Align Technology, Inc. (ALGN) has a market capitalization of $12.46B.
What is Align Technology, Inc.'s P/E ratio?
Align Technology, Inc. trades at a price-to-earnings (P/E) ratio of 28.09.
What exchange does ALGN trade on?
ALGN trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.10-0.38%
$356.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.72-0.39%
$289.31B cap
AstraZeneca PLCLON: AZN
£116.30-0.62%
$243.16B cap